Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) |  Cites / Doc. (2years) |
Ref. / Doc. (2014) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Trends in Pharmacological Sciences | journal | 5.062 Q1 | 244 | 83 | 268 | 6223 | 2661 | 236 | 10.22 | 74.98 |  |
| 2 | Nature Reviews Drug Discovery | journal | 9.338 Q1 | 391 | 227 | 655 | 8790 | 6590 | 297 | 9.38 | 38.72 | |
| 3 | Neuropsychopharmacology | journal | 3.821 Q1 | 249 | 324 | 811 | 16259 | 5954 | 742 | 6.84 | 50.18 | |
| 4 | Drug Discovery Today | journal | 1.865 Q1 | 215 | 251 | 468 | 16300 | 2909 | 431 | 6.44 | 64.94 | |
| 5 | Clinical Pharmacokinetics | journal | 1.928 Q1 | 184 | 83 | 195 | 5545 | 1171 | 189 | 5.73 | 66.81 | |
| 6 | Neuropharmacology | journal | 2.410 Q1 | 191 | 423 | 1166 | 32705 | 6304 | 1145 | 5.65 | 77.32 | |
| 7 | Journal of Antimicrobial Chemotherapy | journal | 2.298 Q1 | 221 | 703 | 1596 | 20600 | 8395 | 1319 | 5.20 | 29.30 | |
| 8 | Expert Opinion on Therapeutic Targets | journal | 1.990 Q1 | 106 | 116 | 380 | 11340 | 1797 | 367 | 4.78 | 97.76 | |
| 9 | Pharmacogenomics Journal | journal | 1.648 Q1 | 95 | 78 | 187 | 3479 | 930 | 187 | 4.76 | 44.60 | |
| 10 | Expert Opinion on Therapeutic Patents | journal | 1.310 Q1 | 88 | 102 | 324 | 8692 | 1270 | 323 | 4.42 | 85.22 | |
| 11 | Journal of Psychopharmacology | journal | 1.659 Q1 | 135 | 134 | 471 | 7855 | 1966 | 446 | 4.35 | 58.62 | |
| 12 | International Journal of Neuropsychopharmacology | journal | 1.924 Q1 | 125 | 219 | 445 | 12164 | 2061 | 433 | 4.27 | 55.54 | |
| 13 | Expert Opinion on Investigational Drugs | journal | 1.431 Q1 | 117 | 140 | 442 | 11529 | 1741 | 434 | 4.18 | 82.35 | |
| 14 | BMC Pharmacology | journal | 0.968 Q2 | 48 | 0 | 22 | 0 | 59 | 22 | 4.00 | 0.00 | |
| 15 | Expert Opinion on Biological Therapy | journal | 1.326 Q1 | 102 | 162 | 487 | 11723 | 1875 | 476 | 3.97 | 72.36 | |
| 16 | Therapeutic Advances in Neurological Disorders | journal | 1.267 Q1 | 68 | 25 | 86 | 1144 | 356 | 83 | 3.88 | 45.76 | |
| 17 | Expert Review of Vaccines | journal | 1.533 Q1 | 105 | 167 | 459 | 14550 | 1767 | 393 | 3.85 | 87.13 | |
| 18 | British Journal of Clinical Pharmacology | journal | 1.487 Q1 | 167 | 273 | 758 | 10601 | 2837 | 610 | 3.64 | 38.83 | |
| 19 | BioDrugs | journal | 0.875 Q2 | 79 | 48 | 146 | 2839 | 412 | 144 | 3.40 | 59.15 | |
| 20 | CNS Neuroscience and Therapeutics | journal | 1.619 Q1 | 91 | 149 | 398 | 6211 | 1442 | 306 | 3.37 | 41.68 | |
| 21 | Drug Safety | journal | 1.238 Q1 | 140 | 95 | 321 | 4352 | 1058 | 282 | 3.30 | 45.81 | |
| 22 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.906 Q2 | 100 | 127 | 375 | 11853 | 1234 | 373 | 3.30 | 93.33 | |
| 23 | BMC Clinical Pharmacology | journal | 0.883 Q2 | 43 | 0 | 37 | 0 | 113 | 37 | 3.29 | 0.00 | |
| 24 | Expert Opinion on Emerging Drugs | journal | 0.982 Q2 | 54 | 41 | 129 | 3944 | 391 | 126 | 3.18 | 96.20 | |
| 25 | Antiviral Therapy | journal | 1.541 Q1 | 93 | 107 | 473 | 3662 | 1522 | 455 | 3.13 | 34.22 | |
| 26 | Molecular Diagnosis and Therapy | journal | 0.977 Q2 | 68 | 82 | 105 | 4660 | 295 | 102 | 3.10 | 56.83 | |
| 27 | Phytotherapy Research | journal | 0.940 Q2 | 158 | 257 | 865 | 9955 | 2531 | 865 | 2.94 | 38.74 | |
| 28 | Expert Opinion on Pharmacotherapy | journal | 0.764 Q2 | 93 | 243 | 750 | 16898 | 2033 | 718 | 2.91 | 69.54 | |
| 29 | ChemMedChem | journal | 1.110 | 119 | 320 | 688 | 12177 | 1932 | 668 | 2.76 | 38.05 | |
| 30 | Cardiovascular Therapeutics | journal | 1.051 Q2 | 54 | 46 | 203 | 1736 | 552 | 194 | 2.75 | 37.74 | |
| 31 | Biopharmaceutics and Drug Disposition | journal | 0.637 Q2 | 65 | 48 | 149 | 2036 | 418 | 143 | 2.73 | 42.42 | |
| 32 | Acta Pharmacologica Sinica | journal | 1.054 Q2 | 117 | 163 | 586 | 5725 | 1508 | 571 | 2.66 | 35.12 | |
| 33 | Chemical Biology and Drug Design | journal | 0.818 | 91 | 153 | 543 | 5433 | 1452 | 524 | 2.58 | 35.51 | |
| 34 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.061 Q1 | 57 | 56 | 168 | 3331 | 457 | 163 | 2.55 | 59.48 | |
| 35 | Journal of Pharmacy and Pharmacology | journal | 0.711 Q2 | 137 | 180 | 557 | 7269 | 1440 | 551 | 2.55 | 40.38 | |
| 36 | PharmacoEconomics | journal | 1.203 Q1 | 118 | 108 | 270 | 4933 | 708 | 232 | 2.49 | 45.68 | |
| 37 | RSC Medicinal Chemistry | journal | 74 | 231 | 594 | 10372 | 1542 | 575 | 2.48 | 44.90 | | |
| 38 | Future Medicinal Chemistry | journal | 1.114 Q1 | 90 | 171 | 563 | 11950 | 1507 | 450 | 2.43 | 69.88 | |
| 39 | Clinical and Experimental Pharmacology and Physiology | journal | 1.042 Q2 | 115 | 132 | 423 | 5878 | 1007 | 366 | 2.36 | 44.53 | |
| 40 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.619 Q2 | 92 | 120 | 393 | 4478 | 821 | 391 | 2.35 | 37.32 | |
| 41 | Pharmacogenomics | journal | 0.965 Q2 | 100 | 193 | 606 | 9357 | 1578 | 506 | 2.35 | 48.48 | |
| 42 | BMC pharmacology & toxicology | journal | 0.715 Q2 | 43 | 77 | 83 | 2511 | 191 | 79 | 2.30 | 32.61 | |
| 43 | Xenobiotica | journal | 0.681 Q2 | 89 | 119 | 350 | 4645 | 792 | 343 | 2.27 | 39.03 | |
| 44 | Fundamental and Clinical Pharmacology | journal | 0.700 Q2 | 85 | 73 | 242 | 3202 | 541 | 242 | 2.26 | 43.86 | |
| 45 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.738 Q2 | 81 | 111 | 318 | 3633 | 730 | 315 | 2.26 | 32.73 | |
| 46 | Journal for ImmunoTherapy of Cancer | journal | 0.486 Q3 | 117 | 42 | 21 | 1801 | 47 | 20 | 2.24 | 42.88 | |
| 47 | Antiviral Chemistry and Chemotherapy | journal | 0.677 Q2 | 59 | 12 | 47 | 573 | 116 | 45 | 2.17 | 47.75 | |
| 48 | Chinese Medicine | journal | 0.771 Q2 | 56 | 27 | 93 | 1337 | 262 | 90 | 2.00 | 49.52 | |
| 49 | Biomedical Chromatography | journal | 0.638 Q2 | 71 | 241 | 628 | 6599 | 1214 | 619 | 1.86 | 27.38 | |
| 50 | Clinical Trials | journal | 1.302 Q1 | 74 | 84 | 281 | 2004 | 488 | 232 | 1.85 | 23.86 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data